Antithymocyte globulin (ATG) 2.5 and 0.5 mg/kg reduces loss of β-cell function in young people with recent-onset type 1 diabetes.
A RECENT multi-centre, adaptive phase 2 trial has found that low-dose antithymocyte globulin (ATG) preserves β-cell function ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback